Stock Fundamentals

Company Information

Company Name
BioLineRx Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US09071M3043
CIK: 0001498403
CUSIP: 09071M205
Currency: USD
Full Time Employees: 20
Phone: 972 8 642 9100
Fiscal Year End: December
IPO Date: Jul 25, 2011
Description:

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Address:

Modi?in Technology Park, Hevel Modi'in, Israel, 7177871

Directors & Officers

Name Title Year Born
Mr. Philip A. Serlin CPA, M.B.A. Chief Executive Officer 1960
Dr. Ella Sorani Ph.D. Chief Development Officer 1968
Mr. John Lacey Head of Corporate Communications & Investor Relations NA
Mr. Raziel Fried Treasurer & Budgetary Control Director NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
XTX Topco Ltd 10.94K Mar 31, 2026 0.25% $0.00 0.00%
Rhumbline Advisers 2.35K Mar 31, 2026 0.05% $0.00 -29.82%
BNP Paribas Arbitrage, SA 1.80K Mar 31, 2026 0.04% $0.00 20.00%
Wells Fargo & Co 1.75K Mar 31, 2026 0.04% $0.00 0.00%
Citigroup Inc 1.73K Mar 31, 2026 0.04% $0.00 -15.21%
UBS Group AG 529.00 Mar 31, 2026 0.01% $0.00 -72.89%
Goss Wealth Management LLC 107.00 Dec 31, 2025 0.00% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 100.00 Mar 31, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 26.00 Mar 31, 2026 0.00% $0.00 0.00%
Rockefeller Capital Management L.P. 12.00 Mar 31, 2026 0.00% $0.00 0.00%
Danske Bank A/S. 2.00 Mar 31, 2026 0.00% $0.00 0.00%
Tower Research Capital LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
ACT Capital Management, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Citadel Advisors Llc 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Urban Wealth Management, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
SBI Securities Co Ltd 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Bank of America Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 4.35M
Shares Float: 4.16M
% Insiders: 398.00%
% Institutions: 44.90%
Short % Float: 3.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 999.00 0.04% ▲ 0.00% Mar 31, 2025

Valuation Metrics

Enterprise Value: $5.81M
Trailing P/E: 0.00
Forward P/E: 93.46

Financial Highlights

Market Cap: $15.16M
EBITDA: $-10.75M
P/E Ratio: $0.00
PEG Ratio: $0.20
Book Value: $3.60
Earnings/Share: $0.00
Profit Margin: 0.00%
Operating Margin: -629.77%
ROA (TTM): -16.55%
ROE (TTM): -46.72%
Revenue (TTM): $1.40M
Revenue/Share (TTM): $0.60
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 87.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.95x 0.50x 0.43x -8.04x -40.81x
2024-12-31 1.76x 1.04x 0.65x -2.23x 3.56x
2023-12-31 1.10x 0.78x 0.79x -22.91x -0.18x
2022-12-31 4.87x 0.21x 0.33x -13.51x -0.48x
2021-12-31 5.91x 0.04x 0.16x -25.18x -0.12x
2020-12-31 2.15x 0.27x 0.53x -15.60x -0.22x
2019-12-31 2.36x 0.26x 0.38x -15.37x -0.38x
2018-12-31 4.74x 0.21x 0.27x -1,219.29x -0.40x
2017-12-31 7.49x 0.00x 0.13x -1,201.90x -0.01x
2016-12-31 9.86x 0.01x 0.10x -1,179.50x -0.02x
2015-12-31 15.34x 0.01x 0.07x -1,079.73x -0.03x
2014-12-31 12.10x 0.00x 0.12x -41.92x 0.00x
2013-12-31 6.15x 0.00x 0.41x -822.68x 0.00x
2012-12-31 3.45x 0.00x 0.38x -814.52x 0.00x
2011-12-31 4.02x 0.00x 0.23x -14.61x -0.01x
2010-12-31 6.59x 0.01x 0.15x 222.70x 0.05x
2009-12-31 3.57x 0.00x 0.26x N/A 0.00x
2008-12-31 2.75x 0.00x 0.32x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BLRX.US!